Literature DB >> 25055831

Concerns over data in key dabigatran trial.

Deborah Cohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25055831     DOI: 10.1136/bmj.g4747

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  Analgesic use before and after oral anticoagulant initiation--a population-based study in Finland.

Authors:  Jenni Ilomäki; Arja Helin-Salmivaara; Risto Huupponen; Maria Rikala; Carl M Kirkpatrick; Maarit Jaana Korhonen
Journal:  Eur J Clin Pharmacol       Date:  2015-04-26       Impact factor: 2.953

2.  Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017.

Authors:  Junya Zhu; G Caleb Alexander; Saman Nazarian; Jodi B Segal; Albert W Wu
Journal:  Pharmacotherapy       Date:  2018-07-26       Impact factor: 4.705

3.  The criteria of the Italian Federation of Thrombosis Centres on DOACs: a "real world" application in nonvalvular atrial fibrillation patients already on vitamin K antagonist.

Authors:  Doris Barcellona; Miro Luzza; Nicola Battino; Lara Fenu; Francesco Marongiu
Journal:  Intern Emerg Med       Date:  2014-12-09       Impact factor: 3.397

Review 4.  Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy.

Authors:  Michelangelo Sartori; Benilde Cosmi
Journal:  J Thromb Thrombolysis       Date:  2018-04       Impact factor: 2.300

5.  Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVAL.

Authors:  Jürgen H Prochaska; Sebastian Göbel; Karsten Keller; Meike Coldewey; Alexander Ullmann; Heidrun Lamparter; Claus Jünger; Zaid Al-Bayati; Christina Baer; Ulrich Walter; Christoph Bickel; Hugo ten Cate; Thomas Münzel; Philipp S Wild
Journal:  BMC Med       Date:  2015-01-23       Impact factor: 8.775

6.  The Dabigatran debate.

Authors:  Riyaz A Kaba; Farhana Ara; David E Ward; Subo Emanuel
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16

7.  Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study.

Authors:  Shirley V Wang; Jessica M Franklin; Robert J Glynn; Sebastian Schneeweiss; Wesley Eddings; Joshua J Gagne
Journal:  BMJ       Date:  2016-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.